# Mesalamine

NDC: 0472-1915
Generic name: Mesalamine
Labeler / Manufacturer: Actavis Pharma, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: SUPPOSITORY
Routes: RECTAL
Marketing started: 20210423
Marketing ended: 20261130
FDA application: ANDA205654

## Active ingredients

- MESALAMINE: 1000 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0472-1915"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0472-1915
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=73317da3-cba0-4106-9e88-79b0e2f642af